t
Kanabo Group PLC announced on March 24, 2025, that Ian Mattioli resigned as a Non-Executive Director. This resignation was effective immediately.
| Date | 24 Mar 2025 |
| Time | 11:02:49 |
| Category | Board changes |
| ID | 8857B |
("Kanabo" or the "Company")
London, UK - March 24, 2025 - Kanabo Group PLC, a leader in digital health services and specialised medicines (including medicinal cannabis), announces that Ian Mattioli, Non-Executive Director of the Company, has resigned with immediate effect.
Due to health and personal reasons, Ian will spend more time committed to his other business interests and the Board takes the opportunity to thank Ian for his commitment to the Company during his tenure.
Enquiries:
|
Kanabo Group plc Avihu Tamir, Chief Executive Officer Odelia Vazana, Chief Financial Officer
|
+44 (0)20 7469 0930 |
|
Peterhouse Capital Limited (Financial Adviser and Broker) Guy Miller / Lucy Williams / Charles Goodfellow
|
+44 (0)20 7469 0930 |
About Kanabo Group plc (LSE: KNB) Kanabo Group plc is a digital health company committed to improving patient care through its specialised technology platform and treatments, including medicinal cannabis.
Kanabo's NHS-approved telehealth platform, The GP Service, provides video consultations, online prescriptions, and comprehensive primary care. Treat It, the Company's specialised clinic, extends these services to chronic pain management and mental health indications, offering patients access to secondary care.
With two complementary business divisions, Kanabo delivers end-to-end digital health solutions, from telehealth consultations and prescriptions to tailored treatments. Its partially owned subsidiary, Kanabo Agritec Ltd, offers cultivation consultancy, enabling reliable access to high-quality raw materials for Kanabo's product range.
Kanabo Group plc remains focused on delivering high-quality medical solutions that make healthcare more accessible for patients across the UK and beyond.